Facebook
X
LinkedIn
ForwardDDI-fficult Decisions: Navigating Drug Interactions in Oral Oncology Regimens Recorded Presentation
This continuing education course will cover the clinically significant drug–drug interactions (DDIs) associated with oral anticancer therapies. The presentation will cover potential adverse effects of DDIs and examine key interaction pathways, including those involving CYP3A4 inhibitors and inducers, gastric acid–suppressing agents, and medications that prolong the QT interval. Strategies for identifying, preventing, and managing these interactions will be discussed to help ensure patient safety and maintain optimal therapeutic efficacy.
If you attended DDI-fficult Decisions: Navigating Drug Interactions in Oral Oncology Regimens on February 12, 2026, you will not be able to claim credit again for this course. However, you are welcome to still watch the content.
Target Audience
This course is intended for Advocate Pharmacists, Physicians, Nurses, and other interested healthcare professionals
Learning Objectives
At the end of this session, learners should be able to:
- Identify oral oncology agents with high drug–drug interaction (DDI) risk and describe the key pharmacokinetic and pharmacodynamic mechanisms that contribute to potential interaction.
- Explain how drug interactions involving CYP3A4 inhibitors and inducers influence clinical outcomes.
- Describe the ways acid-suppressing agents interact with oral chemotherapy therapies and summarize considerations for management.
- Explain how QT-prolonging agents interact with oral chemotherapy and outline key principles to monitor and prevent QTc prolongation.
Faculty
Sandi Thein Sein, PharmD, PGY2 Oncology Pharmacy Resident – Aurora St. Luke's Medical Center
Disclosure
The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose.
Accreditation Statement
In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Statement(s)
American Medical Association (AMA)
Advocate Health designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Advocate Health designates this enduring activity for a maximum of 1.00 ANCC contact hours/APRN pharmacological hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Council for Pharmacy Education (ACPE)
Advocate Health designates this enduring activity for a maximum 1.00 hours of CPE credit for (pharmacists and pharmacy technicians). CPE credit can be claimed on the AAH CE platform within 60 days of activity completion and information will be provided to CPE Monitor. Participants should only claim credit commensurate with the extent of their participation in the activity.
UAN: JA0006327-0000-26-053-H01-P
Available Credit
- 1.00 AMA PRA Category 1 Credit™Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 1.00 AttendanceAttendance Credit
- 1.00 Approved AMA PRA Category 1 Credit™
- 1.00 Continuing Nursing Education (CE)Aurora Health Care is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 1.00 contact hours have been awarded to this activity by the Wisconsin Nursing Association. To receive contact hours, participants must attend the entire activity.
- 1.00 Continuing Pharmacy Education (CPE)Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Price
How to Register
Click “Take Course” to complete this program.
If you attended DDI-fficult Decisions: Navigating Drug Interactions in Oral Oncology Regimens on February 12, 2026, you will not be able to claim credit again for this course. However, you are welcome to still watch the content.
Participation Options
This course is available to Advocate Health providers (employed and independent) and team members only.
For Further Information
Contact the AH Continuing Pharmacy Education team at [email protected] if you have any questions or need assistance.
If you have any questions regarding registration, please contact the IPCE Office at [email protected]